Thomas Verron

A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers

Grant C. O’Connell, J. Pritchard, Chris Prue et al. · Internal and Emergency Medicine · 2019 · 111 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data

Layla Malt, Thomas Verron, Xavier Cahours et al. · Harm Reduction Journal · 2020 · 53 citations · Full text

Public Health, Population Health Sciences, Population Health +9

Some theoretical properties of the O‐PLS method

Thomas Verron, Robert Sabatier, Richard Joffre · Journal of Chemometrics · 2004 · 45 citations

Natural Sciences, Soil Sciences, Analytical Chemistry +6

Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu™ electronic nicotine delivery systems (ENDS)

Paul W. Morris, Simon McDermott, Fiona Chapman et al. · Internal and Emergency Medicine · 2021 · 35 citations · Full text

Pharmacy, Toxicology, Environmental Toxicology +15

Multi-endpoint analysis of human 3D airway epithelium following repeated exposure to whole electronic vapor product aerosol or cigarette smoke

Lukasz Czekala, Roman Wieczorek, Liam Simms et al. · Current Research in Toxicology · 2021 · 24 citations · Full text

Pharmacy, Toxicology, Molecular Toxicology +16